Dilation and evacuation: a preferred method of midtrimester abortion

Area of Science:

• Obstetrics and Gynecology
• Reproductive Health

Background:

• Midtrimester pregnancy termination is a critical aspect of reproductive healthcare.
• Various methods exist, each with associated risks and benefits.

Purpose of the Study:

• To compare the safety and efficacy of two methods for therapeutic termination of midtrimester pregnancies: dilation and evacuation (D and E) and prostaglandin F2 alpha instillation.
• To evaluate complication rates, hospital stay duration, and blood loss for each method.

Main Methods:

• A comparative study involving 58 patients undergoing therapeutic termination of pregnancy.
• Group 1: 29 patients (13-16 weeks' gestation) underwent dilation and evacuation (D and E).
• Group 2: 29 patients (16-19 weeks' gestation) underwent therapeutic abortion via prostaglandin F2 alpha instillation.

Main Results:

• The D and E group exhibited a significantly lower complication rate (6.9%) compared to the prostaglandin group (55%).
• Patients undergoing D and E had a shorter hospital stay, averaging 1 full day less.
• Blood loss was not significantly greater in the D and E group.

Conclusions:

• Dilation and evacuation (D and E) is a more favorable method for midtrimester pregnancy termination due to its lower complication rate and shorter hospital stay.
• Prostaglandin F2 alpha instillation is associated with a substantially higher complication rate in this gestational range.